Concepedia

G Sędek

GS

19

Publications

756

Citations

16

H-Index

1972

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Novartis (France)

Postgraduate School of Molecular Medicine

Roche (Switzerland)

G Sędek is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1972–2009

19

Publications

19

Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients

Gilbert Lefèvre, G Sędek, S. S. Jhee et al. · Clinical Pharmacology & Therapeutics · 2007 · 126 citations · Full text

Pharmacokinetic‐pharmacodynamic interaction between the COMT inhibitor tolcapone and single‐dose levodopa.

Jasper Dingemanse, Karin Jorga, G. Zürcher et al. · British Journal of Clinical Pharmacology · 1995 · 113 citations · Full text

, , +13

Multiple-dose clinical pharmacology of the catechol- O -methyl-transferase inhibitor tolcapone in elderly subjects

Jasper Dingemanse, Karin Jorga, G. Zürcher et al. · European Journal of Clinical Pharmacology · 1996 · 63 citations

, , +6

Pharmacokinetics of a Rivastigmine Transdermal Patch Formulation in Healthy Volunteers: Relative Effects of Body Site Application

Gilbert Lefèvre, G Sędek, Hsun‐Lun Aaron Huang et al. · The Journal of Clinical Pharmacology · 2007 · 60 citations

Estimation of the Absolute Bioavailability of Rivastigmine in Patients with Mild to Moderate Dementia of the Alzheimer???s Type

Mohammad Sharif Hossain, Stanford S. Jhee, Thomas Shiovitz et al. · Clinical Pharmacokinetics · 2002 · 59 citations

, , +11

Rows per page

1–5 of 19